コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ic integration mechanisms and the impacts of viral integration.
2 s, both genes are highly expressed following viral integration.
3 ty of leukemias and lymphomas as a result of viral integration.
4 on surrounding c-myc is indeed a hot spot of viral integration.
5 lular sequence was not linked to the site of viral integration.
6 ociation with both spcDNAs and hot-spots for viral integration.
7 understanding of the molecular mechanisms of viral integration.
8 a translocation had occurred at the site of viral integration.
9 tandard deviations away from samples without viral integration.
10 ional activation, cancer, viral latency, and viral integration.
11 enomic 'safe harbor' site rather than random viral integration.
12 ase of the tethered p12 post mitosis, before viral integration.
13 t virus-induced cell killing is triggered by viral integration.
14 chromosomal rearrangements in cancer and of viral integration.
15 T antigen that provides indirect evidence of viral integration.
16 ce-inducing substitutions were defective for viral integration.
17 nses and possible gene alterations following viral integration.
18 ll specific, and inhibition occurs following viral integration.
19 captured to quantify the number of distinct viral integrations.
20 virome-wide screening of early-stage clonal viral integrations.
21 existing methods and software for detecting viral integrations.
22 luding homeobox A9 (Hoxa9)/myeloid ecotropic viral integration 1 (Meis1)/pre-B-cell leukemia homeobox
23 A was found in primary infection, whereas in viral integration, 4 patients had HHV-6A and 17 patients
25 t genetic rearrangement in processes such as viral integration and excision and chromosomal segregati
26 terial chromosome dimers to adeno-associated viral integration and is a versatile tool for mammalian
27 chromosome remodelling, viral replication or viral integration and may account for the local hypermet
28 th host chromatin and significantly impaired viral integration and replication in HIV-1-susceptible c
29 ween viral integrase and LEDGF/p75, reducing viral integration and retargeting the provirus to region
31 s study, we set out to identify the sites of viral integration and to assess the efficiency of the ov
32 a cytolytic effect on infected cells before viral integration, and a direct, non-cytolytic effect by
33 ciated with activating PIK3CA alterations or viral integration, and also expressed higher levels of H
35 splantation showed sustained Btk expression, viral integration, and partial functional responses, con
36 53) in viral entry, a karyopherin (TNPO3) in viral integration, and the Mediator complex (Med28) in v
37 s the hypothesis that the sites of oncogenic viral integration are nonrandom and that genes at the si
41 and FGFR3, enrichment of APOBEC mutagenesis, viral integration at known hotspots, and frequent epigen
45 itself is weak without hormonal stimulation, viral integration can position the 5' LTR elements to ef
47 rtant for basic cellular functions including viral integration, control of gene expression, productio
48 tage or metastatic potential, as a result of viral integration either affecting the cellular genes wh
49 Strikingly, our analysis revealed non-clonal viral integrations even in individuals without cancer.
50 vitro integration junctions suggest that the viral integration event itself is mediated by terminal r
51 rst molecular characterization of an in vivo viral integration event within a confirmed fragile site
52 xperimental evidence that the high number of viral integration events (>90%) found in actively expres
55 However, when the inhibitor was added after viral integration had occurred, no inhibition of HIV inf
56 We propose that activation of DNA-PK during viral integration has a central role in CD4(+) T-cell de
63 omain and was identified as a common site of viral integration in myeloid leukemias arising in BXH-2
64 was originally isolated as a common site of viral integration in myeloid tumors of the BXH-2 recombi
66 nd interpreted these findings as evidence of viral integration in the human genome as a potential pat
67 , the Hoxa-9 gene is frequently activated by viral integration in the same BXH-2 leukemias, suggestin
70 nologies have been widely used to screen for viral integrations in cancer genomes, and a number of bi
71 ults provide evidence for some of the oldest viral integrations in the human genome and insights into
74 , and have all of the hallmarks of authentic viral integration, including the removal of a terminal T
75 hed adjacent normal samples, indicating that viral integration induced host driver genetic alteration
78 of early cervical lesions revealed frequent viral integration into gene-poor regions of the host gen
79 Evidence from several studies indicates that viral integration into genic regions is accompanied by l
81 xpansion of latently infected T cells due to viral integration into specific genes contribute to this
83 both human and HPV38 genomes, indicative of viral integration into the host DNA, something not previ
91 are nonrandom and that genes at the sites of viral integration may play important roles in carcinogen
92 s of these patterns can provide insight into viral integration mechanisms, pathology and genome evolu
94 0% of TBLV-induced lymphomas have detectable viral integrations near c-myc by Southern blotting, wher
97 BV) infection are urgently needed because of viral integration, persistence of viral antigen expressi
98 verified experiments show that more than 90% viral integration sequences detected by seeksv are true.
99 ed to block IN-LEDGF/p75 interactions during viral integration, several of these compounds have been
103 on, we identified a potent myeloid ecotropic viral integration site (MEIS) inhibitor, MEISi-1, to ind
104 eukemia homeobox (PBX) and myeloid ecotropic viral integration site (MEIS) proteins control cell fate
105 homeobox (KNOX) and animal Myeloid ecotropic viral integration site (MEIS) proteins share a TALE home
108 In addition, aberrant expression of ectopic viral integration site 1 (EVI1) has also been found in s
110 the transforming potential of the ecotropic viral integration site 1 (Evi1) oncogene is thought to b
117 The pivotal role of the myeloid ecotropic viral integration site 1 (MEIS1) transcriptional factor
119 ption factor 1) and MEIS1 (myeloid ecotropic viral integration site 1 homolog), and remain so until t
121 transcriptional signature of EVI1 (ecotropic viral integration site 1)-rearranged (EVI1-r) acute myel
125 nd 4, a major fragile region that includes a viral integration site between exons 4 and 5, and cancer
128 some (BAC) clone, RP364B14, corresponding to viral integration site in CRL2504 cells, reverted their
129 ecific chromosomal conformation mapping, and viral integration site sequencing (IS-seq) to frontal co
130 motifs corresponded to MEIS (myeloid ectopic viral integration site) transcription factors, suggestin
131 andmarks, five cancer cell break points, one viral integration site, and one aphidicolin break cluste
132 proximately 18 kb upstream of another common viral integration site, Gfi1, on mouse chromosome 5.
141 NC tumors and keratinocyte clones identified viral integration sites in a variety of chromosomes, wit
143 fication of genes located in the vicinity of viral integration sites in human cancers may be helpful
146 is, we carried out a genome-wide analysis of viral integration sites in the prostate cell line DU145
150 model to identify both CIS genes and unique viral integration sites or compare the integration sites
152 tumor-associated DNA viruses and identifying viral integration sites that may unravel novel mechanism
153 is, decreased infectivity, and redistributed viral integration sites to markers associated with late
157 various sizes as well as translocations and viral integration sites with high sensitivity and low fa
158 rse collection of genomic perturbations near viral integration sites, including direct gene disruptio
165 d VIcaller, a novel platform for identifying viral integrations that are derived from any characteriz
166 te significantly to the observed increase in viral integrations that specify a Switching phenotype, p
167 rus (AAV) is unique in its ability to target viral integration to a specific site on chromosome 19 (c
169 , HPV18 and adeno-associated virus-2 (AAV2), viral integration was associated with local variations i
170 Dysregulation of a host gene disrupted by viral integration was defined by aberrant expression >2
171 sure of cells to zidovudine, indicating that viral integration was not required to induce secretion.
178 significantly greater reduction in distinct viral integrations, with 3.28-fold and 1.81-fold decreas
179 bitors, which could block one of the ends of viral integration, would lead to similar aberrant integr